CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Embryo Development Corp. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Embryo Development Corp.
305 Madison Avenue
Suite 4510
Phone: (212) 808-0607p:212 808-0607 New York, NY  10165  United States Ticker: EMBREMBR

This company is no longer actively traded on any major stock exchange.

Business Summary
Embryo Development Corp. (Embryo) is a shell company. The Company's activities are limited and are focused on pursuing an acquisition or other form of reorganization. Embryo was formed to develop, acquire, manufacture and market various bio-medical devices throughout the United States. The Company holds 4.4% interest in Nesco Industries, Inc., (Nesco). It had originally acquired this interest through the acquisition, in 1997, of a majority interest in Hydrogel Design Systems, Inc. (HDS). HDS was a consolidated subsidiary of the Company. Pursuant to a share exchange agreement, as amended, initially dated, as of April 10, 2004 (the YBR Agreement), by and among the Company, Yellow Brick Road Ventures LLC (YBR) and Music Asset Corp. (MAC), the Company agreed to acquire from YBR, 100% of the outstanding stock of MAC.
(Source: 10KSB)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
7/31/20064/30/2006YesYes---

Industries
SIC Code Description
6726 Unit investment trusts, face-amount certificate offices

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Chief Financial Officer and Director Matthew L.Harriton 42 4/1/1997 1/1/1996
Director DanielDurchslag 61

General Information
Number of Employees: 1 (As of 7/15/2006)
Outstanding Shares: 6,745,000 (As of 8/18/2006)
Shareholders: 673
Stock Exchange: OTC
Federal Tax Id: 133832099
Fax Number: (212) 486-0831


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023